Oncogene - Table of Contents alert Volume 35 Issue 9

If you are unable to see the message below, click here to view.

Advertisement Four million CpGs - the best in bisulfite sequencing Diagenode's Premium RRBS kit uses a unique protocol for highest efficiency of bisulfite conversion and minimal bias. Lowest cost solution available! Superior coverage - 4 million CpGs Cost-efficient - Multiplex up to 6 samples/lane Complete kit from conversion to library preparation reagents   Learn more TABLE OF CONTENTS Volume 35, Issue 9 (March 2016) In this issue Reviews Original Articles Short Communications Corrigendum Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Oncogenesis Focus Collection: Cancer & Metabolism While extremely diverse in origin, all cancer cells show profound metabolic changes. The articles in this Special Issue discuss the connection between cancer cells and their metabolic adaptations, from molecular mechanisms to anticancer therapies, and highlight the dialogue between whole organism and cancer cells. Explore the Special Issue in full. Reviews Top Opportunities and challenges provided by crosstalk between signalling pathways in cancer A Prahallad and R Bernards Oncogene 2016 35: 1073-1079; advance online publication, May 18, 2015; 10.1038/onc.2015.151 Abstract | Full Text Rethinking pheochromocytomas and paragangliomas from a genomic perspective L J Castro-Vega, C Lepoutre-Lussey, A-P Gimenez-Roqueplo and J Favier Oncogene 2016 35: 1080-1089; advance online publication, June 1, 2015; 10.1038/onc.2015.172 Abstract | Full Text Role of HOXA9 in leukemia: dysregulation, cofactors and essential targets C T Collins and J L Hess Oncogene 2016 35: 1090-1098; advance online publication, June 1, 2015; 10.1038/onc.2015.174 Abstract | Full Text Original Articles Top Stromal fibroblasts facilitate cancer cell invasion by a novel invadopodia-independent matrix degradation process H Cao, R D Eppinga, G L Razidlo, E W Krueger, J Chen, L Qiang and M A McNiven Oncogene 2016 35: 1099-1110; advance online publication, May 18, 2015; 10.1038/onc.2015.163 Abstract | Full Text IMP3 promotes stem-like properties in triple-negative breast cancer by regulating SLUG S Samanta, H Sun, H L Goel, B Pursell, C Chang, A Khan, D L Greiner, S Cao, E Lim, L D Shultz and A M Mercurio Oncogene 2016 35: 1111-1121; advance online publication, May 18, 2015; 10.1038/onc.2015.164 Abstract | Full Text LASP-1: a nuclear hub for the UHRF1-DNMT1-G9a-Snail1 complex N Duvall-Noelle, A Karwandyar, A Richmond and D Raman Oncogene 2016 35: 1122-1133; advance online publication, May 18, 2015; 10.1038/onc.2015.166 Abstract | Full Text miR-520h is crucial for DAPK2 regulation and breast cancer progression C-M Su, M-Y Wang, C-C Hong, H-A Chen, Y-H Su, C-H Wu, M-T Huang, Y-W Chang, S-S Jiang, S-Y Sung, J-Y Chang, L-T Chen, P-S Chen and J-L Su Oncogene 2016 35: 1134-1142; advance online publication, May 18, 2015; 10.1038/onc.2015.168 Abstract | Full Text Decreased LRIG1 in fulvestrant-treated luminal breast cancer cells permits ErbB3 upregulation and increased growth M M Morrison, M M Williams, D B Vaught, D Hicks, J Lim, C McKernan, L Aurisicchio, G Ciliberto, C Simion, C Sweeney and R S Cook Oncogene 2016 35: 1143-1152; advance online publication, July 6, 2015; 10.1038/onc.2015.169 Abstract | Full Text Prostate-specific G-protein-coupled receptor collaborates with loss of PTEN to promote prostate cancer progression M Rodriguez, S Siwko, L Zeng, J Li, Z Yi and M Liu Oncogene 2016 35: 1153-1162; advance online publication, June 1, 2015; 10.1038/onc.2015.170 Abstract | Full Text Frequent promoter hypermethylation of PTPRT increases STAT3 activation and sensitivity to STAT3 inhibition in head and neck cancer N D Peyser, M Freilino, L Wang, Y Zeng, H Li, D E Johnson and J R Grandis Oncogene 2016 35: 1163-1169; advance online publication, May 18, 2015; 10.1038/onc.2015.171 Abstract | Full Text Cyclin-dependent kinase 2 (CDK2) is a key mediator for EGF-induced cell transformation mediated through the ELK4/c-Fos signaling pathway C Peng, W Zeng, J Su, Y Kuang, Y He, S Zhao, J Zhang, W Ma, A M Bode, Z Dong and X Chen Oncogene 2016 35: 1170-1179; advance online publication, June 1, 2015; 10.1038/onc.2015.175 Abstract | Full Text A microRNA code for prostate cancer metastasis OPEN D Bonci, V Coppola, M Patrizii, A Addario, A Cannistraci, F Francescangeli, R Pecci, G Muto, D Collura, R Bedini, A Zeuner, M Valtieri, S Sentinelli, M S Benassi, M Gallucci, P Carlini, S Piccolo and R De Maria Oncogene 2016 35: 1180-1192; advance online publication, June 15, 2015; 10.1038/onc.2015.176 Abstract | Full Text Short Communications Top Scribble acts as an oncogene in Eμ-myc-driven lymphoma E D Hawkins, J Oliaro, K M Ramsbottom, A Newbold, P O Humbert, R W Johnstone and S M Russell Oncogene 2016 35: 1193-1197; advance online publication, May 18, 2015; 10.1038/onc.2015.167 Abstract | Full Text Oncogenic activation of the PI3-kinase p110β isoform via the tumor-derived PIK3CβD1067V kinase domain mutation E Pazarentzos, P Giannikopoulos, G Hrustanovic, J St John, V R Olivas, M A Gubens, R Balassanian, J Weissman, W Polkinghorn and T G Bivona Oncogene 2016 35: 1198-1205; advance online publication, May 18, 2015; 10.1038/onc.2015.173 Abstract | Full Text Corrigendum Top Decreased LRIG1 in fulvestrant-treated luminal breast cancer cells permits ErbB3 upregulation and increased growth M M Morrison, M M Williams, D B Vaught, D Hicks, J Lim, C McKernan, L Aurisicchio, G Ciliberto, C Simion, C Sweeney and R S Cook Oncogene 2016 35: 1206; 10.1038/onc.2015.418 Full Text Advertisement The Geoffrey Beene Cancer Research Center at Memorial Sloan Kettering Cancer Center, Nature, Nature Cell Biology and Nature Reviews Cancer present: CANCER AS AN EVOLVING AND SYSTEMIC DISEASE March 12-15, 2016 | New York, NY, USA REGISTER NOW! Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.